Screening for Thrombophilia

Obstetrics and Gynecology Clinics of North America

Volumn 33, Issue 3, 2006, Pages 389-395

  Blickstein, Dorit ^a  

^a RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FAMILY STUDY; FEMALE; HIGH RISK PATIENT; HORMONAL THERAPY; HUMAN; LABORATORY TEST; MEDICAL SPECIALIST; PATIENT COUNSELING; PHYSICIAN; PREGNANCY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SCREENING TEST; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

AGE FACTORS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOPHILIA;

EID: 33748477672     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2006.05.005     Document Type: Review

References (27)

1. Wu O., Robertson L., Twaddle S., et al. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol 131 (2005) 80-90
2. Middeldorp S., Meinardi J.R., Koopman M.M., et al. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Ann Intern Med 135 (2001) 322-327
3. Simioni P., Tormene D., Prandoni P., et al. Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood 99 (2002) 1938-1942
4. Martinelli I. Pros and cons of thrombophilia testing: pros. J Thromb Haemost 1 (2003) 410-411
5. Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology. Investigation and management of heritable thrombophilia. Br J Haematol 114 (2001) 512-528
6. Nicolaides A.N. Thrombophilia and venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence. Int Angiol 24 (2005) 1-26
7. Jordaan D.J., Schoon M.G., and Badenhorst P.N. Thrombophilia screening in pregnancy. Obstet Gynecol Surv 60 (2005) 394-404
8. Lockwood C.J. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 99 (2002) 333-341
9. Caprini J.A., Goldshteyn S., Glase C.J., et al. Thrombophilia testing in patients with venous thrombosis. Eur J Vasc Endovasc Surg 30 (2005) 550-555
10. Mannucci P.M. Laboratory detection of inherited thrombophilia: a historical perspective. Semin Thromb Hemost 31 (2005) 5-10
11. Grody W.W., Griffin J.H., Taylor A.K., et al. ACMG Factor V. Leiden Working Group. American College of Medical Genetics consensus statement on factor V Leiden mutation testing. Genet Med 3 (2001) 139-148
12. Bates S.M., Greer I.A., Hirsh J., et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 627S-644S
13. Carraro P. European Communities Confederation of Clinical Chemistry and Laboratory Medicine, Working Group on Guidelines for Investigation of Disease. Guidelines for the laboratory investigation of inherited thrombophilias: recommendations for the first level clinical laboratories. Clin Chem Lab Med 41 (2003) 382-391
14. Seligsohn U., and Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 344 (2001) 1222-1231
15. Cushman M. Inherited risk factors for venous thrombosis. Hematology Am Soc Hematol Educ Program (2005) 452-457
16. Mack R., Chowdary D., Streck D., et al. Inherited thrombophilia genes in minorities. Genet Test 3 (1999) 371-373
17. Baglin T. Management of thrombophilia: who to screen?. Pathophysiol Haemost Thromb 33 (2003) 401-404
18. Machin S.J. Pros and cons of thrombophilia testing: cons. J Thromb Haemost 1 (2003) 412-413
19. Weitz J.I., Middeldorp S., Geerts W., et al. Thrombophilia and new anticoagulant drugs. Hematology Am Soc Hematol Educ Program (2004) 424-438
20. Rosendaal F.R. Oral contraceptives and screening for factor V Leiden. Thromb Haemost 75 (1996) 524-525
21. Bloemenkamp K.W., Rosendaal F.R., Helmerhorst F.M., et al. Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Arch Intern Med 160 (2000) 49-52
22. Miall F.M., Deol P.S., Barnes T.A., et al. Coagulation status and complications of pregnancy. Thromb Res 115 (2005) 461-467
23. Luddington R.J. Thrombelastography/thromboelastometry. Clin Lab Haematol 27 (2005) 81-90
24. Toulon P., and Perez P. Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway. Hematol Oncol Clin North Am 14 (2000) 379-389
25. Toulon P., Adda R., and Perez P. Sensitivity of the ProC global assay for protein C pathway abnormalities: clinical experience in 899 unselected patients with venous thromboembolism. Thromb Res 104 (2001) 93-103
26. Sarig G., Lanir N., Hoffman R., et al. Protein C global assay in the evaluation of women with idiopathic pregnancy loss. Thromb Haemost 88 (2002) 32-36
27. Grand'Maison A., Bates S.M., Johnston M., et al. ProC Global: a functional screening test that predicts recurrent venous thromboembolism. Thromb Haemost 93 (2005) 600-604